McGarr P L, Madiba T E, Thomson S R, Corr P
Department of Surgery, University of Natal and King Edward VIII Hospital, Durban.
S Afr Med J. 2003 Feb;93(2):132-6.
To evaluate the safety and efficacy of conservative management of amoebic liver abscesses.
A prospective study carried out over a 1-year period.
Inpatients and outpatients in a tertiary referral institution.
Amoebic liver abscess was diagnosed on clinical, ultrasonographic, and serological features. All patients were treated with metronidazole. The indication for ultrasound-guided aspiration of the abscess was failure to improve clinically within 48-72 hours.
Clinical improvement, clinical deterioration and failure of clinical improvement (persistent pain).
In total 178 patients (male-to-female ratio 5:1) with 203 abscesses were treated during this period. Of these, 23 patients required percutaneous aspiration and 150 patients were managed without intervention and clinically resolved spontaneously. Abscesses requiring aspiration tended to be larger than those managed without aspiration (10.7 cm v. 8.2 cm) (p = 0.003). There were no complications following aspiration. Mean hospital stay was longer (12.3 days) for patients who underwent aspiration compared with those who did not (6.7 days) (p = 0.031). Only 5 patients presented with ruptured abscesses, 1 cutaneously and 4 intraperitoneally, with the only death in this latter category.
Conservative medical management of amoebic liver abscess is safe. Percutaneous ultrasound-guided aspiration is indicated only in patients who fail to improve clinically after 48-72 hours rather than on rigid criteria.
评估阿米巴肝脓肿保守治疗的安全性和有效性。
一项为期1年的前瞻性研究。
一家三级转诊机构的住院患者和门诊患者。
根据临床、超声和血清学特征诊断为阿米巴肝脓肿。所有患者均接受甲硝唑治疗。脓肿超声引导下穿刺的指征是在48 - 72小时内临床症状未改善。
临床改善、临床恶化和临床改善失败(持续性疼痛)。
在此期间共治疗了178例患者(男女比例为5:1),有203个脓肿。其中,23例患者需要经皮穿刺抽吸,150例患者未接受干预,临床症状自发缓解。需要穿刺抽吸的脓肿往往比未穿刺抽吸的脓肿更大(10.7厘米对8.2厘米)(p = 0.003)。穿刺抽吸后无并发症发生。与未接受穿刺抽吸的患者相比,接受穿刺抽吸的患者平均住院时间更长(12.3天对6.7天)(p = 0.031)。仅5例患者出现脓肿破裂,1例为皮肤破裂,4例为腹腔内破裂,后者中有1例死亡。
阿米巴肝脓肿的保守药物治疗是安全的。经皮超声引导下穿刺抽吸仅适用于在48 - 72小时后临床症状未改善的患者,而非依据严格标准。